Nervous System Disease: Clinical Trials

2 trials for Nervous System Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Active not recruiting 1, Completed 1

Follow Nervous System Disease: new trials by email Literature Review of Nervous System Disease trials Research Report on Nervous System Disease

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 3 Study of NTLA-2001 in ATTRv-PN
nexiguran ziclumeran, Normal Saline as Placebo - Neuromuscular Disease, Neuromuscular Diseases (NMD)
Phase 3Active not recruitingIntellia Therapeutics672024-11-222026-11-05
Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Telangiectasia Patients
EryDex Low dose DSP, EryDex High dose DSP, Pooled Placebo - Nervous System Disease, Genetic Syndrome
Phase 3CompletedQuince Therapeutics S.p.A.1762017-03-022024-05-10

Narrower conditions

Genetic Diseases, Inborn (2)  ·  Nervous System Diseases (2)  ·  Amyloid Neuropathies (1)  ·  Amyloid Neuropathies, Familial (1)  ·  Amyloidosis (1)  ·  Amyloidosis, Familial (1)  ·  Amyloidosis, Hereditary, Transthyretin-Related (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Metabolic Diseases (1)  ·  Metabolism, Inborn Errors (1)  ·  Neurodegenerative Diseases (1)  ·  Neuromuscular Diseases (1)  ·  Peripheral Nervous System Diseases (1)  ·  Polyneuropathies (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Nutritional and Metabolic Diseases (1)  ·  Proteostasis Deficiencies (1)

Interventions

NTLA-2001 (1)  ·  Saline Solution (1)

Sponsors

Intellia Therapeutics (1)  ·  Quince Therapeutics S.p.A. (1)

Countries

Argentina (1)  ·  Australia (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Germany (1)  ·  India (1)  ·  Israel (1)  ·  Italy (1)  ·  Mexico (1)  ·  Norway (1)  ·  Poland (1)  ·  Singapore (1)  ·  Spain (1)  ·  Taiwan (1)  ·  Thailand (1)

Top investigators

Guenter R. Janhofer, MD, PhD (1)

Results publications

PMID 39152028, PMID 39917433

NIH funding

2015 (1)